NDC 78206-158

REMERONSOLTAB

Mirtazapine

REMERONSOLTAB is a Oral Tablet, Orally Disintegrating in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Mirtazapine.

Product ID78206-158_98f8806d-a77a-4c45-aa6d-29378a52a682
NDC78206-158
Product TypeHuman Prescription Drug
Proprietary NameREMERONSOLTAB
Generic NameMirtazapine
Dosage FormTablet, Orally Disintegrating
Route of AdministrationORAL
Marketing Start Date2021-06-01
Marketing CategoryNDA /
Application NumberNDA021208
Labeler NameOrganon LLC
Substance NameMIRTAZAPINE
Active Ingredient Strength30 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 78206-158-01

5 BLISTER PACK in 1 BOX (78206-158-01) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (78206-158-99)
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "REMERONSOLTAB" or generic name "Mirtazapine"

NDCBrand NameGeneric Name
0052-0106REMERONSOLTABMIRTAZAPINE
0052-0108REMERONSOLTABMIRTAZAPINE
0052-0110REMERONSOLTABMIRTAZAPINE
0093-7206MirtazapineMirtazapine
0093-7207MirtazapineMirtazapine
0093-7208MirtazapineMirtazapine
0115-1653MirtazapineMirtazapine
0115-1654MirtazapineMirtazapine
0115-1656MirtazapineMirtazapine
0185-0020mirtazapinemirtazapine
0185-0212mirtazapinemirtazapine
0185-0222mirtazapinemirtazapine
0378-3515MirtazapineMirtazapine
0378-3530MirtazapineMirtazapine
0052-0105REMERONMIRTAZAPINE
0052-0107REMERONMIRTAZAPINE
0052-0109REMERONMIRTAZAPINE
0052-4364REMERONMIRTAZAPINE
0052-4365REMERONMIRTAZAPINE

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.